Panion & BF Biotech Aug revenue NT$181.2M vs NT$251.3M
Panion & BF Biotech reported 2026 Aug revenue of NT$181,232,000 versus NT$251,306,000 in 2025, with Jan–Aug revenue at NT$1,385,567,000 versus NT$1,381,495,000.
Panion & BF Biotech Inc. said revenue for 2026 was NT$181,232,000, compared with NT$251,306,000 in 2025. For Jan-Aug, revenue was NT$1,385,567,000 versus NT$1,381,495,000 a year earlier. Figures are in New Taiwan dollars.
Source: Taiwan Stock Exchange.